Your browser doesn't support javascript.
loading
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.
Shearer, William T; Dunn, Elizabeth; Notarangelo, Luigi D; Dvorak, Christopher C; Puck, Jennifer M; Logan, Brent R; Griffith, Linda M; Kohn, Donald B; O'Reilly, Richard J; Fleisher, Thomas A; Pai, Sung-Yun; Martinez, Caridad A; Buckley, Rebecca H; Cowan, Morton J.
Afiliação
  • Shearer WT; Department of Pediatrics, Section of Immunology, Allergy, and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, Tex. Electronic address: wtshearer@texaschildrens.org.
  • Dunn E; Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif.
  • Notarangelo LD; Division of Biostatistics, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, Wis.
  • Dvorak CC; Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif.
  • Puck JM; Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif.
  • Logan BR; Division of Immunology and the Manton Center for Orphan Disease Research, Children's Hospital Boston, and Harvard Stem Cell Institute, Harvard Medical School, Boston, Mass.
  • Griffith LM; Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
  • Kohn DB; Departments of Microbiology, Immunology & Molecular Genetics and Pediatrics, University of California, Los Angeles, Calif.
  • O'Reilly RJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Fleisher TA; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md.
  • Pai SY; Division of Hematology and Oncology, Boston Children's Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Mass.
  • Martinez CA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital Cancer Center, Houston, Tex.
  • Buckley RH; Department of Pediatrics and Immunology, Duke University Medical Center, Durham, NC.
  • Cowan MJ; Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif.
J Allergy Clin Immunol ; 133(4): 1092-8, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24290292
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência Combinada Severa Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência Combinada Severa Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2014 Tipo de documento: Article